Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Anticancer Research|July 31, 2012
First-line bevacizumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimisation analysisVirginie Nerich, Fernando Bazan, Fanny Compagnat, et al.
Oncology Reports|January 19, 2017
Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumorsDavid Guenat, Olivier Deroo, Sandrine Magnin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2006
Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancerPhilippe Fagnoni, Samuel Limat, Loïc Chaigneau, et al.
Oncology|October 25, 2022
Real-World Experience of Efficacy and Safety of Trabectedin in Patients with Soft Tissue Sarcoma: A Bicentric Retrospective AnalysisLoïc Chaigneau, Marine Jary, Virginie Nerich, et al.
Anticancer Research|April 12, 2012
Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injuryElsa Curtit, Loïc Chaigneau, Julien Pauchot, et al.
Drugs|July 21, 2011
Cabazitaxel: a novel microtubule inhibitorCristian Villanueva, Fernando Bazan, Stefano Kim, et al.
Bulletin Du Cancer|September 13, 2011
[Follow-up in patients with early breast cancer]Tristan Maurina, Loïc Chaigneau, Fernando Bazan, et al.
Clinical Drug Investigation|September 26, 2016
Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal TumorsVirginie Nerich, Camille Fleck, Loïc Chaigneau, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2012
Specific anticancer treatments in the last 3 months of life: a French experienceErika Viel, Loïc Chaigneau, Eleonor Fanton, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 26, 2013
First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimization analysisVirginie Nerich, Jennifer Chelly, Philippe Montcuquet, et al.
Pageof 5